Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial.
Näslund U, Ng N, Lundgren A, Fhärm E, Grönlund C, Johansson H, Lindahl B, Lindahl B, Lindvall K, Nilsson SK, Nordin M, Nordin S, Nyman E, Rocklöv J, Vanoli D, Weinehall L, Wennberg P, Wester P, Norberg M; VIPVIZA trial group. Näslund U, et al. Among authors: nyman e. Lancet. 2019 Jan 12;393(10167):133-142. doi: 10.1016/S0140-6736(18)32818-6. Epub 2018 Dec 3. Lancet. 2019. PMID: 30522919 Clinical Trial.
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial.
Bengtsson A, Norberg M, Ng N, Carlberg B, Grönlund C, Hultdin J, Lindahl B, Lindahl B, Nordin S, Nyman E, Wennberg P, Wester P, Näslund U. Bengtsson A, et al. Among authors: nyman e. Am J Prev Cardiol. 2021 May 21;7:100199. doi: 10.1016/j.ajpc.2021.100199. eCollection 2021 Sep. Am J Prev Cardiol. 2021. PMID: 34611639 Free PMC article.
Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA-A randomised controlled trial.
Nyman E, Grönlund C, Vanoli D, Liv P, Norberg M, Bengtsson A, Wennberg P, Wester P, Näslund U; VIPVIZA trial group. Nyman E, et al. Clin Physiol Funct Imaging. 2023 Jul;43(4):232-241. doi: 10.1111/cpf.12811. Epub 2023 Jan 27. Clin Physiol Funct Imaging. 2023. PMID: 36642849 Clinical Trial.
Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis.
Bengtsson A, Nyman E, Grönlund C, Wester P, Näslund U, Fhärm E, Norberg M. Bengtsson A, et al. Among authors: nyman e. Int J Cardiovasc Imaging. 2023 Aug;39(8):1461-1471. doi: 10.1007/s10554-023-02868-0. Epub 2023 May 30. Int J Cardiovasc Imaging. 2023. PMID: 37249653 Free PMC article.
140 results